RonanRx, Inc. dba RonanRx
Has RonanRx, Inc. dba RonanRx received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued RonanRx, Inc. dba RonanRx a warning letter naming semaglutide and tirzepatide, dated Oct 30, 2026, with the FDA subject line “False & Misleading Claims/Misbranded (Telehealth).”
FDA records in this index name RonanRx, Inc. dba RonanRx on Oct 30, 2026.
- Websites the letters name
- ronanrx.com (see how each letter refers to them)
- Type named in FDA records
- Telehealth
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide, Tirzepatide
- Latest record
- Oct 30, 2026
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Oct 30, 2026 | False & Misleading Claims/Misbranded (Telehealth) | Semaglutide, Tirzepatide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Oct 30, 2026: … your website offers compounded drug products, including semaglutide and tirzepatide products. 1 As described below, … website’s false or misleading claims concerning compounded semaglutide and tirzepatide products under sections 502(a) … or misleading representations regarding your compounded semaglutide and tirzepatide products. Under section 502(a) of … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- ronanrx.com: FDA’s warning letter of Oct 30, 2026 is addressed to RonanRx, Inc. dba RonanRx. It refers to the site in these words: “FDA Review Violations were identified and documented during a review of RonanRx’s website, https://ronanrx.com and associated social media platforms, FDA Establishment Identifier (FEI) 3048890334, in September 2026.” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.